Abstract
Companies stepping up to assist during the COVID-19 pandemic face hard choices in a new risk environment.
Original language | English |
---|---|
Journal | MIT Sloan Management Review |
Publication status | Published - 29 Sept 2020 |
Keywords
- Ethics
- compliance
- Crisis
- pandemic
- COVID-19
- pharmaceutical company
- healthcare